Fundaro Paolo
Director, 10% owner at INTERCEPT PHARMACEUTICALS INC
- Sold, on record
- $125M
- Dollars the filings state
- Form 4 sales
- 8
- Latest Aug 17, 2020
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- INTERCEPT PHARMACEUTICALS INCDirector, 10% owner
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale INTERCEPT PHARMACEUTICALS INCUnusualAug 12, 2013 2013
Sold 4,759 shares at $46.13 ($220k)
Fundaro Paolo, Director
Sold 78.2% of holdings ($281k position)1,330 shares leftFirst sale on recordFiling
- 2 Form 4 sale INTERCEPT PHARMACEUTICALS INCUnusualFeb 14, 2014 +186 days
Sold 7,246 shares at $375.26 ($2.7M)
Fundaro Paolo, Director
Sold 81.4% of holdings ($3.3M position)1,655 shares leftFiling
- 3 Form 4 sale INTERCEPT PHARMACEUTICALS INCPlan not statedMay 9, 2014 +84 days
Sold 325 shares at $232.00 ($75k)
Fundaro Paolo, Director
Sold 16.4% of holdings ($459k position)1,655 shares leftFiling
- 4 Form 4 sale INTERCEPT PHARMACEUTICALS INCPlan not statedAug 11, 2014 +94 days
Sold 324 shares at $239.49 ($78k)
Fundaro Paolo, Director
Sold 3.5% of holdings ($2.2M position)8,803 shares left0.1x usual sizeFiling
- 5 Form 4 sale INTERCEPT PHARMACEUTICALS INCPlan not statedJul 24, 2015 +347 days
Sold 582 shares at $285.00 ($166k)
Fundaro Paolo, Director
Sold 6.6% of holdings ($2.5M position)8,221 shares left0.2x usual sizeFiling
- 6 Form 4 sale INTERCEPT PHARMACEUTICALS INCPlan not statedMar 29, 2019 +1344 days
Sold 2,171 shares at $107.45 ($233k)
Fundaro Paolo, Director
Sold 16.3% of holdings ($1.4M position)11,114 shares leftFirst sale on recordFiling
- 7 Form 4 sale INTERCEPT PHARMACEUTICALS INCPlan not statedMay 13, 2020 +411 days
Sold 595,578 shares at $84.60 ($50.4M)
Fundaro Paolo, Director, 10% owner
Sold 9.8% of holdings ($516M position)5.5M shares leftFiling
- 8 Form 4 sale INTERCEPT PHARMACEUTICALS INCUnusualAug 17, 2020 +96 days
Sold 1.5M shares at $47.50 ($71.2M)
Fundaro Paolo, Director, 10% owner
Sold 27.3% of holdings ($261M position)4M shares leftFiling
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2020 | Aug 17, 2020 | INTERCEPT PHARMACEUTICALS INC | Director, 10% owner | Form 4 sale | 1.5M | $71.2M | 27.3% | Unusual | SEC |
| May 13, 2020 | May 15, 2020 | INTERCEPT PHARMACEUTICALS INC | Director, 10% owner | Form 4 sale | 595,578 | $50.4M | 9.8% | Plan not stated | SEC |
| Mar 29, 2019 | Mar 29, 2019 | INTERCEPT PHARMACEUTICALS INC | Director | Form 4 sale | 2,171 | $233k | 16.3% | Plan not stated | SEC |
| Jul 24, 2015 | Jul 24, 2015 | INTERCEPT PHARMACEUTICALS INC | Director | Form 4 sale | 582 | $166k | 6.6% | Plan not stated | SEC |
| Aug 11, 2014 | Aug 12, 2014 | INTERCEPT PHARMACEUTICALS INC | Director | Form 4 sale | 324 | $78k | 3.5% | Plan not stated | SEC |
| May 9, 2014 | May 9, 2014 | INTERCEPT PHARMACEUTICALS INC | Director | Form 4 sale | 325 | $75k | 16.4% | Plan not stated | SEC |
| Feb 14, 2014 | Feb 14, 2014 | INTERCEPT PHARMACEUTICALS INC | Director | Form 4 sale | 7,246 | $2.7M | 81.4% | Unusual | SEC |
| Aug 12, 2013 | Aug 13, 2013 | INTERCEPT PHARMACEUTICALS INC | Director | Form 4 sale | 4,759 | $220k | 78.2% | Unusual | SEC |